MUVON Therapeutics

MUVON is the acronym for Muscle, Volt and ON from "switch on", that is for the muscle that is activated by means of electromagnetic stimulation. At the same time, the name is a phonetic call to action: move on – move forward! After a decade of interdisciplinary research at the UZH, the spin-off MUVON Therapeutics was founded. The first objective of the company is to market the regenerative treatment of stress urinary incontinence. Currently at the end of Phase 1 clinical trial, the team was supported by Wyss Zurich for bringing the therapy through the upcoming phase2. In the future, the plan is to expand the autologous transplantation, i.e. the transplantation of cells removed from the patient's own body, to other skeletal muscles as well.